Last $141.51 USD
Change Today -0.35 / -0.25%
Volume 3.0M
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas O. Daniel M.D.

Executive Vice President and President of Research & Early Development, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 41 board members in 3 different organizations across 6 different industries.

See Board Relationships
59$3,558,584
As of Fiscal Year 2012

Background*

Dr. Thomas O. Daniel, M.D., has been the President of Research & Early development of Celgene Corporation since December 2006 and has been its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen Washington ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Director
2012-Present
Director and Member of Compensation Committee

Education*

MD
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

Salary$625,000
Total Annual Compensation$625,000

Stock Options*

Restricted Stock Awards$1,018,083
All Other Compensation$97,685
Exercisable Options137,398
Unexercisable Options86,902
Total Number of Options224,300

Total Compensation*

Total Annual Cash Compensation$1,582,678
Total Short Term Compensation$625,000
Other Long Term Compensation$1,115,768
Total Calculated Compensation$3,558,584
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $141.51 USD -0.35

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.3M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.3M
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer and Director
Shire plc
$2.7M
Haruo Naito Chief Executive Officer, President and Director
Eisai Co., Ltd.
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.